000 00598nam a2200133 4500
008 250430b |||||||| |||| 00| 0 eng d
100 _aShalini virani
245 _aEfficacy,safety, and cost-effectiveness of biosimilars of bevacizumab in naive patients with diabetic macular edema
300 _aPP248-252
654 _aAnti-vascular endothelial growth factor
_abevacizumab
_abiosimilars
_acost-effectiveness
_adiabetic macular edema
700 _aAkshay bhatiwal
_aParveen Rewri
773 0 _0125270
_9112013
_dMumbai Wolters Kluwer India
_tIndian Journal of Pharmacology
_x0253-7613
942 _cJA
999 _c131661
_d131661